Connection
David Hall to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications David Hall has written about Carcinoma, Non-Small-Cell Lung.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.224 |
|
|
|
-
Ortendahl JD, Cuyun Carter G, Thakkar SG, Bognar K, Hall DW, Abdou Y, Gandara D. Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non-Small Cell Lung Cancer. JCO Precis Oncol. 2025 Jun; 9:e2400640.
Score: 0.117
-
Ortendahl JD, Cuyun Carter G, Thakkar SG, Bognar K, Hall DW, Abdou Y. Value of next generation sequencing (NGS) testing in advanced cancer patients. J Med Econ. 2024 Jan-Dec; 27(1):519-530.
Score: 0.108